# Revolution Medicines, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/revolution-medicines-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 19 |
| Claims under review | 1 |
| Evidence records | 10 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-16T13:54:58.592666+00:00 |
| Last reviewed | 2026-10-16T13:54:58.592666+00:00 |

## Identity

- Legal name: Revolution Medicines, Inc.
- Display name: Revolution Medicines, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-17T00:45:44.589406+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.767 |
| Directors | 4 |
| Committees | 1 |
| Governance events | 5 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Frank K. Clyburn, Jr.: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:6
- Sandra J. Horning, M.D.: Director. Status: current. Independent: true. Since: 2023-01-01. claim_id=alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:7
- Sushil Patel, Ph.D.: Director. Status: current. Independent: true. Since: 2022-01-01. claim_id=alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:8
- Thilo Schroeder, Ph.D.: Director. Status: current. Independent: true. Since: 2018-01-01. claim_id=alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:9

## Committees

- Compensation (compensation). Chair: NOT_PUBLISHED. Members: Frank K. Clyburn, Jr. (member, current). committee_id=alpha:committee:revolution-medicines-inc:compensation

## Executive leadership

- Alan Sandler: Chief Development Officer. Status: unknown. claim_id=alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:10
- Anthony Mancini: Chief Global Commercialization Officer. Status: unknown. claim_id=alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:11
- Jack Anders: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:12
- Jeffrey Cislini: Senior Vice President, General Counsel and Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:13
- Margaret Horn: Chief Operating Officer [COO]. Status: unknown. claim_id=alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:14
- Mark A. Goldsmith: Chief Executive Officer, President and Chair of the Board [CEO]. Status: unknown. claim_id=alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:15
- Stephen M. Kelsey: President, Research and Development [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:16

## Governance events

- DIRECTOR_APPOINTED: Frank K. Clyburn, Jr. seat on Revolution Medicines, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:54:58.592666+00:00. event_id=alpha:event:transition:o4xdsj11fqj9b
- COMMITTEE_MEMBER_ADDED: Frank K. Clyburn, Jr. member of Compensation, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:54:58.592666+00:00. event_id=alpha:event:transition:13lmii3134e0v7
- DIRECTOR_APPOINTED: Sandra J. Horning, M.D. seat on Revolution Medicines, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:54:58.592666+00:00. event_id=alpha:event:transition:1beo9l7orkagd
- DIRECTOR_APPOINTED: Sushil Patel, Ph.D. seat on Revolution Medicines, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-16T13:54:58.592666+00:00. event_id=alpha:event:transition:s34y57321tx3
- DIRECTOR_APPOINTED: Thilo Schroeder, Ph.D. seat on Revolution Medicines, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:54:58.592666+00:00. event_id=alpha:event:transition:10ixmar3dzkkf

## Scoped resources

- `alpha://company/revolution-medicines-inc` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record
- `alpha://company/revolution-medicines-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=identity
- `alpha://company/revolution-medicines-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=corporate-structure
- `alpha://company/revolution-medicines-inc/board` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=board
- `alpha://company/revolution-medicines-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=committees
- `alpha://company/revolution-medicines-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=leadership
- `alpha://company/revolution-medicines-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=ownership
- `alpha://company/revolution-medicines-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=financials
- `alpha://company/revolution-medicines-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=capital-structure
- `alpha://company/revolution-medicines-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=compensation
- `alpha://company/revolution-medicines-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=governance
- `alpha://company/revolution-medicines-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=shareholder-governance
- `alpha://company/revolution-medicines-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=audit
- `alpha://company/revolution-medicines-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=legal
- `alpha://company/revolution-medicines-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=risk
- `alpha://company/revolution-medicines-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=cyber
- `alpha://company/revolution-medicines-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=ai-governance
- `alpha://company/revolution-medicines-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=agents
- `alpha://company/revolution-medicines-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=ecosystem
- `alpha://company/revolution-medicines-inc/events` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=events
- `alpha://company/revolution-medicines-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=relationships
- `alpha://company/revolution-medicines-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=assessments
- `alpha://company/revolution-medicines-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:frank-k-clyburn-jr","name":"Frank K. Clyburn, Jr."},"source_id":"board_seats"}`

## Leadership

- Frank K. Clyburn, Jr.: Director, Compensation. Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:6. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4acaff52cb3ca02cb6c00aea4f95559651ef1e9f92da4abcf24de303f1b415e0.
- Sandra J. Horning, M.D.: Director. Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:7. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4acaff52cb3ca02cb6c00aea4f95559651ef1e9f92da4abcf24de303f1b415e0.
- Sushil Patel, Ph.D.: Director. Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:8. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4acaff52cb3ca02cb6c00aea4f95559651ef1e9f92da4abcf24de303f1b415e0.
- Thilo Schroeder, Ph.D.: Director. Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:9. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4acaff52cb3ca02cb6c00aea4f95559651ef1e9f92da4abcf24de303f1b415e0.
- Alan Sandler: Chief Development Officer. Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:31af6fc4cb28e2df1a6a537fa5149fd1183bf0374da56b3c92a57d8b0e451868.
- Anthony Mancini: Chief Global Commercialization Officer. Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2ffa8480ab4d1c6888ecd1964b286df595d44d23e9028db2246ac257b7420e1b.
- Jack Anders: Chief Financial Officer. Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:112363363654bc2e8da89cff1e41b279978c86ecb9bf3820ab8a2ddb3d43dc6f.
- Jeffrey Cislini: Senior Vice President, General Counsel and Secretary. Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9628b9946166c98323db9fb578bca7e0a071a20893b734ca6a6cef02b31e43e2.
- Margaret Horn: Chief Operating Officer. Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d31fdd026fe70bda79580f3082b7636343016f70f30c3628ca5203e890c768dd.
- Mark A. Goldsmith: Chief Executive Officer, President and Chair of the Board. Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8dc70a9e8d42817db9a9825ad7516edf00703da1aed895b17f0a33731372a0e0.
- Stephen M. Kelsey: President, Research and Development. Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5886d025130f6f506106daf774f43234dc74b182198215d938b1b42352f155ec.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- Compensation: Chair not stated; Members Frank K. Clyburn, Jr.. Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d6a9f2c71627b791a309835000fd694851e412fe9572a66b79b53ccd91403ff8.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Revolution Medicines, Inc.. Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e947691d31aa14087fbde0d070bfee694b1124403cc1ea2378339cfa976ee32c.

## Entity Status

- Public listing published. Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e947691d31aa14087fbde0d070bfee694b1124403cc1ea2378339cfa976ee32c.

## Published Fact

- US. Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e947691d31aa14087fbde0d070bfee694b1124403cc1ea2378339cfa976ee32c.
- Healthcare. Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e947691d31aa14087fbde0d070bfee694b1124403cc1ea2378339cfa976ee32c.

## Committee Appointment

- Frank K. Clyburn, Jr.: member, Compensation. Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d6a9f2c71627b791a309835000fd694851e412fe9572a66b79b53ccd91403ff8.

## Security Listing

- RVMD (NASDAQ). Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:security_listing:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e947691d31aa14087fbde0d070bfee694b1124403cc1ea2378339cfa976ee32c.
- RVMDW (NASDAQ). Claim: alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:security_listing:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e947691d31aa14087fbde0d070bfee694b1124403cc1ea2378339cfa976ee32c.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:e947691d31aa14087fbde0d070bfee694b1124403cc1ea2378339cfa976ee32c: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/revolution-medicines-inc).
- alpha:projection-evidence:document:4acaff52cb3ca02cb6c00aea4f95559651ef1e9f92da4abcf24de303f1b415e0: [Revolution Medicines DEF 14A 2025-04-29](https://www.sec.gov/Archives/edgar/data/1628171/000119312525103947/d942361ddef14a.htm).
- alpha:projection-evidence:document:31af6fc4cb28e2df1a6a537fa5149fd1183bf0374da56b3c92a57d8b0e451868: RVMD executive roster source.
- alpha:projection-evidence:document:2ffa8480ab4d1c6888ecd1964b286df595d44d23e9028db2246ac257b7420e1b: RVMD executive roster source.
- alpha:projection-evidence:document:112363363654bc2e8da89cff1e41b279978c86ecb9bf3820ab8a2ddb3d43dc6f: RVMD executive roster source.
- alpha:projection-evidence:document:9628b9946166c98323db9fb578bca7e0a071a20893b734ca6a6cef02b31e43e2: RVMD executive roster source.
- alpha:projection-evidence:document:d31fdd026fe70bda79580f3082b7636343016f70f30c3628ca5203e890c768dd: RVMD executive roster source.
- alpha:projection-evidence:document:8dc70a9e8d42817db9a9825ad7516edf00703da1aed895b17f0a33731372a0e0: RVMD executive roster source.
- alpha:projection-evidence:document:5886d025130f6f506106daf774f43234dc74b182198215d938b1b42352f155ec: RVMD executive roster source.
- alpha:projection-evidence:d6a9f2c71627b791a309835000fd694851e412fe9572a66b79b53ccd91403ff8: [Compensation](https://www.sec.gov/Archives/edgar/data/1628171/000119312525103947/d942361ddef14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/revolution-medicines-inc)
- [Public Markdown](https://registry.alpha.ac/companies/revolution-medicines-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=jsonld)
- MCP resource: `alpha://companies/revolution-medicines-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-17T00:45:44.404412+00:00; recorded 2026-10-17T00:45:44.404412+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.